A Short-Order Oncology Start-Up: Non-Profit Tackles Drug Shortages
This article was originally published in RPM Report
Executive Summary
Drug shortages are a big problem in cancer, where many generic sterile injectables are both life-saving and irreplaceable. Some oncologists have decided to take control and form a manufacturer of their own.
You may also be interested in...
Who Will Solve The Shortage Problem? Hospital Non-Profit Is Latest Idea
Non-profit probably won’t ever be significant threat to industry – but frustration with chronic shortages could prompt policy changes that are.
Early Notification Legislation: What The Bills Say
Both houses have introduced legislation to require manufacturers to notify FDA in advance of planned interruptions or as soon as possible when facing a shortage. Here’s a look at the details.
ASCO 2023 – A Role For Immuno-Oncology In Ovarian Cancer At Last?
AstraZeneca’s Duo-O trial suggests that excluding Brca-positive patients could be the key to Imfinzi’s apparent success in ovarian cancer.